Ohio Supreme Court to Decide Fate of Controversial Gender-Affirming Care Ban for Children
The Ohio Supreme Court is set to rule on the constitutionality of a 2024 law that bans gender-affirming care for children, a case drawing national attention over how states balance healthcare, parental rights, and child wellbeing.
House Bill 68 prohibits medications and non-surgical treatments commonly used for gender dysphoria and remains in effect during ongoing litigation. While the law also restricts transgender athletes from competing in girls’ sports, that aspect is not part of the current case.
Supporters of the law argue that it protects children by placing healthcare decisions under state regulation rather than allowing treatments that may have long-term, irreversible effects. Ohio Solicitor General Mathura Sridharan emphasized that children do not have a constitutional right to gender-affirming care and that parental discretion over medical treatment is not unlimited. She further argued that lawmakers, rather than medical experts, should define healthcare standards for children.
Opponents, including attorneys representing families of affected children, argue that the law restricts parents from making medical decisions for their children and conflicts with existing protections under the Health Care Freedom Amendment. They contend that denying access to these treatments could impact the wellbeing of children diagnosed with gender dysphoria.
The case raises broader questions about the state’s role in regulating healthcare for children and the balance between legislative authority, parental rights, and safeguarding children’s health. The Ohio Supreme Court’s decision will determine not only the legality of HB 68 but also how far the state can go in limiting access to treatments for children while navigating issues of child protection and parental oversight.
This case highlights the ongoing national debate on healthcare policy, child safety, and the role of government in medical decisions affecting children.
